OA07.03 Limited Knowledge of, Interest in, and Eligibility for Event-Driven PrEP among MSM in Two Samples in the United StatesOral Abstract SessionBehavioural and social science research
OA07.02 “I just decided to stop:” Understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya and its implications for a public health approach to preventionOral Abstract SessionBehavioural and social science research
OA07.01 SMS reminders did not improve PrEP adherence in a randomized controlled trial among young Kenyan womenOral Abstract SessionBehavioural and social science research
OA06.05 A phase I study to assess safety, pharmacokinetics and pharmacodynamics of a topical multipurpose prevention insert containing tenofovir alafenamide fumarate and elvitegravir dosed vaginallyOral Abstract SessionClinical trial results
OA06.04 Heterosexual couples' preferences for dual-purpose prevention products for HIV and pregnancy prevention: the CUPID Study (MTN-045) in Uganda and ZimbabweOral Abstract SessionDelivery technologies: novel approaches, formulation and multi-purpose
OA06.03 Randomized, Placebo Controlled Phase I Trial of Safety, Pharmacokinetics, Pharmacodynamics and Acceptability of a Multipurpose Prevention Vaginal Ring Containing Tenofovir and LevonorgestrelOral Abstract SessionClinical trial results
OA06.02 Randomized, placebo-controlled trial of safety, pharmacokinetics, and pharmacodynamics of 90-day intravaginal rings (IVRs) releasing tenofovir (TFV) with and without levonorgestrel (LNG) among women in Western KenyaOral Abstract SessionDelivery technologies: novel approaches, formulation and multi-purpose
OA06.01 Pharmacokinetics, safety, and vaginal bleeding associated with continuous versus cyclic 90-day use of dapivirine and levonorgestrel vaginal rings for multipurpose prevention of HIV and pregnancyOral Abstract SessionContraception, pregnancy and HIV prevention (incl. PMTCT)
OA05.04 Disruption of immune cell homeostasis within rectal mucosal tissue of HIV+ young men who have sex with menOral Abstract SessionMucosal immunity
OA05.03 Compartment specific changes of Innate Lymphoid Cells within the intestinal mucosa of HIV-1 infected individualsOral Abstract SessionMicrobiome & STI: impact on prevention
seek-warrow-warrow-eseek-e411 - 420 of 444 items